EVALUATION OF PATIENT COUNSELLING THROUGH NEBULIZERS WITH COMORBIDITIES IN TERTIARY CARE HOSPITAL
Kanaganti Swathi, Saga Sunka, Punardeep Roy Karmakar, Sheereen Jahan Begum* and Anikul Islam
ABSTRACT
Aim: To evaluate the patient counselling through Nebulizers with comorbidities. Patients and Methods: All patients with disease complications who used nebulizers had to give written consent to a comprehensive medical history, age, gender, and drugs utilized in nebulizers. Results: In our patients who use nebulizers, we found that DUOLIN is the most commonly prescribed drug, followed by Budecort and Foracort. According to the disease, 42 percent of people have a BA, 77 percent have COPD, 52 percent have LRTI, and 6 percent have LRTI (OTHERS). The information gathered was very good and straightforward. The patient information leaflet was created to help patients understand how to use their nebulizers properly. The research indicates the therapeutic level of nebulizer medicines. determines that patients require medical education to achieve therapeutic levels. Conclusion: According to the findings, the use of nebulizers is widespread among those aged 50 to 80. DUOLIN was most commonly used in 42 percent of cases (BA), 77 percent of cases (COPD), 52 percent of cases (LRTI), and 46% of cases (OTHERS), according to the study. The p-value for all of the data was 0.0001, indicating that the data is significant at 0.05. According to this study, patients who use nebulizers have a low therapeutic level, which is due to a lack of medical expertise about nebulizer use. The patient information leaflet was created to advise patients on the proper use of nebulizers and the medications used in them, as well as their negative effects. This study was undertaken to determine nebulizer usage among 146 patients who most commonly utilized nebulizer drugs, as well as to raise awareness among patients about proper nebulizer usage and educate the public.
Keywords: Patient Counselling, Nebulizer, Respiratory tract Infections.
[Full Text Article]
[Download Certificate]